Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 71611 [2023-22852]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices
Comments should be
addressed to Permit Office, Office of
Polar Programs, National Science
Foundation, 2415 Eisenhower Avenue,
Alexandria, Virginia 22314.
NUCLEAR REGULATORY
COMMISSION
FOR FURTHER INFORMATION CONTACT:
AGENCY:
Andrew Titmus, ACA Permit Officer, at
the above address, 703–292–4479, or
ACApermits@nsf.gov.
SUMMARY:
ADDRESSES:
An
Antarctic meteorite collection,
documentation, and curation plan has
been received from James Karner of the
University of Utah.
SUPPLEMENTARY INFORMATION:
Kimiko S. Bowens-Knox,
Program Analyst, Office of Polar Programs.
[FR Doc. 2023–22622 Filed 10–16–23; 8:45 am]
BILLING CODE 7555–01–P
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on October 23–24, 2023. A sample of
agenda items to be discussed during the
public session includes: an overview of
ICRP 153, a discussion on veterinary
release; financial assurance rulemaking
for disposition of category 1–3. The
agenda is subject to change. The current
agenda and any updates will be
available on the ACMUI’s Meetings and
Related Documents web page at https://
www.nrc.gov/reading-rm/doc-
Link:
https://teams.microsoft.com/dl/launcher/launcher.html?url=%2F_%23%2Fl%2Fmeetup-join%2F19%3Ameeting_
N2NhN2E0NDAtZGM2MC00N2FlLWEzZTAtZDcxN2FlZTg3NWYy%40thread.v2%2F0%3Fcontext%3D
%257b%2522Tid%2522%253a%2522e8d01475-c3b5-436a-a065-5def4c64f52e%2522%
252c%2522Oid%2522%253a%2522304f46bf-32c2-4e0f-912c-878db895e74a%2522%257d%26anon%3Dtrue&
type=meetup-joinamp;deeplinkId=2bb6496e-e273-4726-ade3-ac43b6f94c67&directDl=true&msLaunch=
true&enableMobilePage=false&suppressPrompt=true.
Meeting ID: 220 719 213 35.
Passcode: mkTtLH.
Call in number (audio only): +1 301–576–2978, Silver Spring, MD Phone Conference ID: 353 440 864#.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation: Any member of
the public who wishes to participate in
the meeting in person, via Microsoft
Teams, or via phone should contact Ms.
L. Armstead using the information
below.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter,
M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a
manner that will facilitate the orderly
conduct of business. The following
procedures apply to public participation
in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. L. Armstead
using the contact information listed
above. All submittals must be received
by the close of business on October 18,
2023, and must only pertain to the
topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chair.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/reading-
VerDate Sep<11>2014
17:02 Oct 16, 2023
collections/acmui/meetings/2023.html
or by emailing Ms. L. Armstead at the
contact information below.
FOR FURTHER INFORMATION CONTACT: Ms.
L. Armstead, 301–415–1650, email:
lxa5@nrc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Date and Time for Open Sessions:
October 23, 2023, from 10:00 a.m. to
4:35 p.m. EST.
Date and Time for Closed Session:
October 24, 2023, from 8:30 p.m. to
11:35 p.m. EST. This session will be
closed to conduct the ACMUI’s required
annual training.
Address for Public Meeting: U.S.
Nuclear Regulatory Commission, Two
White Flint North Building (Meeting
Room T2D30), 11555 Rockville Pike,
Rockville, Maryland 20852.
Webinar information
(Microsoft Teams)
Date
October 23, 2023 .................
71611
Jkt 262001
rm/doc-collections/acmui/meetings/
2023.html on or about December 8,
2023.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. L.
Armstead of their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations, Part 7.
Note: This meeting notice was late in order
to adjust the closed session meeting topics to
reflect new internal personnel practices of
the ACMUI.
Dated at Rockville, Maryland this 12th day
of October 2023.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2023–22852 Filed 10–16–23; 8:45 am]
BILLING CODE 7590–01–P
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
POSTAL REGULATORY COMMISSION
[Docket No. R2024–1; Order No. 6730]
Market Dominant Price Adjustment
Postal Regulatory Commission.
Notice.
AGENCY:
ACTION:
The Commission is
recognizing a recently filed Postal
Service notice of inflation-based rate
adjustments affecting market dominant
domestic and international products
and services, along with proposed
classification changes. This notice
informs the public of the filing, invites
public comment, and takes other
administrative steps.
DATES: Comments are due: November 6,
2023.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
SUMMARY:
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 88, Number 199 (Tuesday, October 17, 2023)]
[Notices]
[Page 71611]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22852]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on October 23-24, 2023. A sample of agenda items to be
discussed during the public session includes: an overview of ICRP 153,
a discussion on veterinary release; financial assurance rulemaking for
disposition of category 1-3. The agenda is subject to change. The
current agenda and any updates will be available on the ACMUI's
Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html or by emailing Ms. L.
Armstead at the contact information below.
FOR FURTHER INFORMATION CONTACT: Ms. L. Armstead, 301-415-1650, email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: October 23, 2023, from 10:00 a.m.
to 4:35 p.m. EST.
Date and Time for Closed Session: October 24, 2023, from 8:30 p.m.
to 11:35 p.m. EST. This session will be closed to conduct the ACMUI's
required annual training.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building (Meeting Room T2D30), 11555 Rockville Pike,
Rockville, Maryland 20852.
------------------------------------------------------------------------
Date Webinar information (Microsoft Teams)
------------------------------------------------------------------------
October 23, 2023............. Link:
https://teams.microsoft.com/dl/launcher/launcher.html?url=%2F_%23%2Fl%2Fmeetup-join%2F19%3Ameeting_N2NhN2E0NDAtZGM2MC00N2FlLWEzZTAtZDcxN2FlZTg3NWYy%40thread.v2%2F0%3Fcontext%3D%257b%2522Tid%2522%253a%2522e8d01475-c3b5-436a-a065-5def4c64f52e%2522%252c%2522Oid%2522%253a%2522304f46bf-32c2-4e0f-912c-878db895e74a%2522%257d%26anon%3Dtrue&type=meetup-joinamp;deeplinkId=2bb6496e-
e273-4726-ade3-
ac43b6f94c67&directDl=true&msLaunch=true
&enableMobilePage=false&suppressPrompt=t
rue.
Meeting ID: 220 719 213 35.
Passcode: mkTtLH.
Call in number (audio only): +1 301-576-
2978, Silver Spring, MD Phone Conference
ID: 353 440 864#.
------------------------------------------------------------------------
Public Participation: Any member of the public who wishes to
participate in the meeting in person, via Microsoft Teams, or via phone
should contact Ms. L. Armstead using the information below.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead using the contact information listed
above. All submittals must be received by the close of business on
October 18, 2023, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2023.html on or about December 8, 2023.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Note: This meeting notice was late in order to adjust the closed
session meeting topics to reflect new internal personnel practices
of the ACMUI.
Dated at Rockville, Maryland this 12th day of October 2023.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2023-22852 Filed 10-16-23; 8:45 am]
BILLING CODE 7590-01-P
